Skip to content
MEET YOUR NEXT TOOL

Atlas - AI Research Tool for Nonclinical Regulatory Precedents

Atlas is a free AI research tool that helps drug developers find nonclinical precedents in FDA and EMA review documents. Users ask plain-language questions, and Atlas returns exact regulatory quotes linked to their source pages to aid IND preparation.

Visit tool page
Atlas - AI Research Tool for Nonclinical Regulatory Precedents
Atlas is an AI-powered research tool designed for drug developers preparing Investigational New Drug applications (INDs). It enables users to query FDA and EMA review documents using plain-language questions about nonclinical precedents, such as which species regulators accepted for certain drug modalities. Instead of manually searching through hundreds of pages, users receive exact matching sentences from approved product reviews, linked directly to the page they are sourced from. Atlas covers five drug modalities: bispecifics, antibody-drug conjugates (ADCs), oligonucleotides, gene therapy, and cell therapy. The platform ensures accuracy by verifying quotes against source documents and noting when reviews are silent on queried points. Additional features include a 36-item pre-IND readiness checklist, guidance on first-in-human dosing methods, data on IND clinical holds, a plan benchmarking tool, and alerts for new approvals in selected modalities. Regulatory sources are checked weekly, with monthly update emails provided. Atlas is designed for nonclinical, toxicology, regulatory, and research professionals in biotech companies, as well as consultants and investors, facilitating streamlined and accurate regulatory research and preparation.
Please login to write a review.